102 related articles for article (PubMed ID: 3263402)
1. Inflammation of actinic keratosis caused by systemic chemotherapy--2'-deoxycoformycin.
Camisa C
J Am Acad Dermatol; 1988 Oct; 19(4):758. PubMed ID: 3263402
[No Abstract] [Full Text] [Related]
2. Deoxycoformycin: a new chemotherapeutic agent of interest to dermatologists.
Camisa C; Grever MR; Bouroncle B
J Am Acad Dermatol; 1985 Jun; 12(6):1108-9. PubMed ID: 3874216
[No Abstract] [Full Text] [Related]
3. Hypersensitivity reactions to deoxycoformycin.
O'Dwyer PJ; King SA; Eisenhauer E; Grem JL; Hoth DF
Cancer Chemother Pharmacol; 1989; 23(3):173-5. PubMed ID: 2784360
[TBL] [Abstract][Full Text] [Related]
4. Acute respiratory failure due to 2'Deoxycoformycin.
Kahn RC; Carlon GC; Miller L; Howland WS; Tan C
Intensive Care Med; 1982 Mar; 8(2):101-4. PubMed ID: 7042789
[No Abstract] [Full Text] [Related]
5. Intraglomerular thrombosis with deoxycoformycin--reversible acute renal failure.
Harris DC; Lawrence S; Bradstock KF; Carter JJ; Jones WG
Clin Nephrol; 1984 Mar; 21(3):194-6. PubMed ID: 6608428
[No Abstract] [Full Text] [Related]
6. Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin.
Cummings FJ; Crabtree GW; Wiemann MC; Spremulli EN; Parks RE; Calabresi P
Clin Pharmacol Ther; 1988 Nov; 44(5):501-9. PubMed ID: 3263248
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitivity vasculitis associated with 2-deoxycoformycin and allopurinol therapy.
Steinmetz JC; DeConti R; Ginsburg R
Am J Med; 1989 Apr; 86(4):498-9. PubMed ID: 2784627
[No Abstract] [Full Text] [Related]
8. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
Spiers AS; Moore D; Cassileth PA; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
N Engl J Med; 1987 Apr; 316(14):825-30. PubMed ID: 2434850
[TBL] [Abstract][Full Text] [Related]
9. The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies.
Spiers AS
Blood Rev; 1987 Jun; 1(2):106-10. PubMed ID: 3332090
[TBL] [Abstract][Full Text] [Related]
10. What is the choice of treatment for hairy cell leukemia?
Golomb HM; Ratain MJ; Moormeier J
J Clin Oncol; 1989 Feb; 7(2):156-8. PubMed ID: 2783730
[No Abstract] [Full Text] [Related]
11. Clinical trials in hairy cell leukemia. Current status and future directions.
Cheson BD; Martin A
Ann Intern Med; 1987 Jun; 106(6):871-8. PubMed ID: 3555204
[TBL] [Abstract][Full Text] [Related]
12. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro.
Begleiter A; Glazer RI; Israels LG; Pugh L; Johnston JB
Cancer Res; 1987 May; 47(9):2498-503. PubMed ID: 3494509
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin).
Dang-Vu AP; Olsen EA; Vollmer RT; Greenberg ML; Hershfield MS
J Am Acad Dermatol; 1988 Oct; 19(4):692-8. PubMed ID: 3263401
[TBL] [Abstract][Full Text] [Related]
14. Prolongation of canine skin graft survival by deoxycoformycin.
Epstein RB; Fey T; Sarpel S
Transplantation; 1982 Feb; 33(2):208-9. PubMed ID: 7036476
[No Abstract] [Full Text] [Related]
15. The activity of deoxycoformycin (pentostatin) in refractory leukemias and lymphomas.
Spiers AS
Ann N Y Acad Sci; 1985; 451():138-41. PubMed ID: 3878115
[No Abstract] [Full Text] [Related]
16. Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group.
Johnston JB; Eisenhauer E; Corbett WE; Scott JG; Zaentz SD
J Natl Cancer Inst; 1988 Jul; 80(10):765-9. PubMed ID: 3290498
[TBL] [Abstract][Full Text] [Related]
17. Response to deoxycoformycin in T cell leukaemias.
Catovsky D; Dearden C
Br Med J (Clin Res Ed); 1988 Jan; 296(6618):356. PubMed ID: 2894233
[No Abstract] [Full Text] [Related]
18. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF).
Spiers AS; Parekh SJ
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498
[No Abstract] [Full Text] [Related]
19. 2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.
O'Dwyer PJ; Wagner B; Leyland-Jones B; Wittes RE; Cheson BD; Hoth DF
Ann Intern Med; 1988 May; 108(5):733-43. PubMed ID: 3282467
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic conversion of acute leukaemia from T-lymphoblastic to myeloblastic induced by therapy with 2'-deoxycoformycin.
Murphy SB; Stass S; Kalwinsky D; Rivera G
Br J Haematol; 1983 Oct; 55(2):285-93. PubMed ID: 6604543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
